Anne Wojcicki to buy back 23andMe and its data for $305 million

The possible sale of 23andMe’s genetic data could set a precedent for future cases where companies look to offload increasingly more personal data.

Anne Wojcicki to buy back 23andMe and its data for $305 million

Anne Wojcicki pays $305mn to defeat a previous deal struck with Regeneron Pharmaceuticals

Anne Wojcicki made $305m bid for firm, which has lost customers since declaring bankruptcy, with backing of Fortune 500 company